Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...

Women under age 50 who consume higher amounts of ultraprocessed foods (UPFs) face significantly increased odds of developing ...

Jasmine Eugene, PharmD, explains how pharmacists practicing at the top of their license improve rural oncology access and ...

Patients seeking access to oral acute myeloid leukemia (AML) medications face complex insurance approval processes that can ...

Panelists discuss how managing oral therapy toxicities requires preemptive planning, multidisciplinary team involvement, ...

Panelists discuss how digital therapeutics could address the enormous unmet need for treating negative symptoms in the 60% of ...

Danielle Roman, PharmD, BCOP, discusses the challenges of accessing genomic test results and managing prior authorization in patient care for breast cancer.

Clark Alsfeld, MD, discusses how telemedicine, pharmacists, and evolving policies help overcome financial and geographic ...

Panelists discuss how prescription digital therapeutics like Daylight show promise for treating depression and anxiety but ...

Rural primary care is strained by clinician shortages, limited access, and financial instability, impacting health outcomes and increasing emergency department reliance. National initiatives like the ...

Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...

Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle ...